000136807 001__ 136807
000136807 005__ 20240229105100.0
000136807 0247_ $$2doi$$a10.1007/s00292-018-0435-9
000136807 0247_ $$2pmid$$apmid:29691676
000136807 0247_ $$2ISSN$$a0172-8113
000136807 0247_ $$2ISSN$$a1432-1963
000136807 037__ $$aDKFZ-2018-01245
000136807 041__ $$ager
000136807 082__ $$a610
000136807 1001_ $$aSchüttler, C.$$b0
000136807 245__ $$a[Requirements for a cross-location biobank IT infrastructure : Survey of stakeholder input on the establishment of a biobank network of the German Biobank Alliance (GBA)].
000136807 260__ $$aBerlin$$bSpringer$$c2018
000136807 3367_ $$2DRIVER$$aarticle
000136807 3367_ $$2DataCite$$aOutput Types/Journal article
000136807 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1536236470_3642$$xReview Article
000136807 3367_ $$2BibTeX$$aARTICLE
000136807 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000136807 3367_ $$00$$2EndNote$$aJournal Article
000136807 520__ $$aThe large number of biobanks within Germany results in a high degree of heterogeneity with regard to the IT components used at the respective locations. Within the German Biobank Alliance (GBA), 13 biobanks implement harmonized processes for the provision of biomaterial and accompanying data.The networking of the individual biobanks and the associated harmonisation of the IT infrastructure should facilitate access to biomaterial and related clinical data.For this purpose, the relevant target groups were first identified in order to determine their requirements for IT solutions to be developed in a workshop.Of the seven identified interest groups, three were initially invited to a first round of discussions. The stakeholder input expressed resulted in a catalogue of requirements with regard to IT support for (i) a sample and data request, (ii) the handling of patient consent and inclusion, and (iii) the subsequent evaluation of the sample and data request.The next step is to design the IT solutions as prototypes based on these requirements. In parallel, further user groups are being surveyed in order to be able to further concretise the specifications for development.
000136807 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000136807 588__ $$aDataset connected to CrossRef, PubMed,
000136807 7001_ $$aBuschhüter, N.$$b1
000136807 7001_ $$aDöllinger, C.$$b2
000136807 7001_ $$0P:(DE-HGF)0$$aEbert, L.$$b3
000136807 7001_ $$aHummel, M.$$b4
000136807 7001_ $$aLinde, J.$$b5
000136807 7001_ $$aProkosch, H-U$$b6
000136807 7001_ $$0P:(DE-He78)c0313b77e0c44cd2f5eb85b747c88be0$$aProynova, R.$$b7$$udkfz
000136807 7001_ $$0P:(DE-He78)e4ad7b4e684492de43cfcb12e5397439$$aLablans, Martin$$b8$$eLast author$$udkfz
000136807 773__ $$0PERI:(DE-600)1462980-x$$a10.1007/s00292-018-0435-9$$gVol. 39, no. 4, p. 289 - 296$$n4$$p289 - 296$$tDer Pathologe$$v39$$x1432-1963$$y2018
000136807 909CO $$ooai:inrepo02.dkfz.de:136807$$pVDB
000136807 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000136807 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c0313b77e0c44cd2f5eb85b747c88be0$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000136807 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e4ad7b4e684492de43cfcb12e5397439$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000136807 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000136807 9141_ $$y2018
000136807 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000136807 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPATHOLOGE : 2015
000136807 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000136807 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000136807 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000136807 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000136807 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000136807 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000136807 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000136807 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000136807 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000136807 9201_ $$0I:(DE-He78)G230-20160331$$kG230$$lMedizinische Informatik in der Translationalen Onkologie$$x0
000136807 980__ $$ajournal
000136807 980__ $$aVDB
000136807 980__ $$aI:(DE-He78)G230-20160331
000136807 980__ $$aUNRESTRICTED